Osimertinib With or Without Bevacizumab in Treating Patients With EGFR Positive Non-small Cell Lung Cancer and Brain Metastases
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
M.D. Anderson Cancer Center
University Hospital, Bordeaux
Stanford University
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Fudan University
Tempus AI
Jiangsu Cancer Institute & Hospital
Fundación GECP
Ohio State University Comprehensive Cancer Center
British Columbia Cancer Agency
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
University of Southern Denmark